ASH and The Leukemia & Lymphoma Society (LLS) are collaborating to enhance physician and patient access to clinical trials for hematologic malignancies. LLS’s Clinical Trial Support Center (CTSC) is a free clinical trial resource that clinicians can use to identify appropriate trials from which their patients might benefit.
Data have shown that only 5 to 8 percent of adult patients with cancer enroll onto a clinical trial during their treatment. While it is understood that clinical trials can provide treatment options for many patients with blood cancers, the process of finding clinical trials is complicated and can be overwhelming for patients.
Through the CTSC, ASH member physicians and their care teams, along with patients and caregivers, work one-on-one with LLS’s CTSC Nurse Navigators who provide personal assistance throughout the entire clinical trial process. Nurse Navigators are specially trained in blood cancers, clinical trials, and patient education and support. ASH member physicians, their care teams, and their patients and caregivers have direct access to their CTSC Nurse Navigator for the duration of the search, the enrollment process, and while on a trial.
Easy access to CTSC Nurse Navigators will be available through the ASH portal, which will officially open in January, and Nurse Navigators work with the patients to navigate myriad trial sites, inclusion/exclusion criterion, and other potential barriers to enrollment. These nurses also work in collaboration with the patient’s health care team to provide support, education, and additional resources during the clinical trial process.
Learn more about the process at the LLS booth (#1723) or at the ASH booth (#1701). You can also visit www.hematology.org/clinicaltrialnavigation. Once the portal opens in January, you will log on using your ASH credentials. (If this is your first time referring a patient, watch the orientation webinar first.) Here, members can complete and submit the CTSC referral form. If you have any questions, please email them to email@example.com.
Note: This text has been updated from the Sunday print version and should be considered the article of record.